When an academic inventor presents their invention to the tech transfer office at the school where they work, the licensing officers analyze whether it would be attractive for licensing. If it doesn’t give a commercial entity a competitive advantage in their field, it is unlikely to be desirable for commercial development, so it wouldn’t make […]

The tech transfer office determines if it makes sense to pursue a patent for the invention. They analyze whether the invention has sufficient commercial value and provides licensees with a competitive edge. It must be valuable enough to justify a company paying money to license the IP rights and fund the commercial development costs of […]

If the university has invested in valuable laboratory space for a scientist, they want to see them succeed and move up the ranks to become a respected faculty member. To help them succeed, they will offer some assistance with grant applications. It’s not until someone applies for post-doctoral work that they’re pretty much on their […]

Inventions created from university research used to be federally regulated. The Federal Procurement Regulation contained a patent rights clause that, in many cases, required federal contractors or their inventors to assign their inventions to the federal government unless the funding agency determined that the public interest was better served by allowing the contractor or inventor […]

One counter argument to the pharmaceutical industry conspiracy theory is that it is simply not financially viable for pharmaceutical companies to focus solely on developing cures. While it is true that some diseases can be cured, many others cannot be cured, at least not yet. In these cases, pharmaceutical companies may focus on developing treatments […]